DRKS00020960已完成不适用
Personalized Risk Prediction in Coronary Artery Disease - PRECAD
Deutsches Herzzentrum München der Technischen Universität0 个研究点目标入组 1,400 人开始时间: 2020年4月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •1. Patients 18 years of age or older
- •2. Informed, written consent by the patient
- •3. Coronary angiogram showing one of the following:
- •- coronary three vessel disease, or
- •- coronary two vessel disease, or
- •- exclusion of relevant coronary lesions
排除标准
- •1. Acute myocardial infarction
- •2. Cardiogenic shock, haemodynamic instability
- •3. Active bleeding or clinically important anemia (i.e. <7g/dl)
- •4. Participation in an investigational drug or device study in the last 30 days
- •5. Pregnancy or lactation
- •6. Any other severe comorbidity such as active cancer with life expectancy less than 12 months.
研究者
相似试验
尚未招募
Unknown
cardiovascular risk prediction as per prakritiCTRI/2024/05/067087Chaudhary Brahm Prakash ayurved Charak Sansthan
招募中
Unknown
The New predictiVe factors that drIve coronary atheroscleroSIs follOwiNg Coronary Artery Disease (VISION-CAD)” studyCoronary artery diseaseIschaemic heart diseaseCardiovascularCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemCardiovascular - Coronary heart diseaseAtherosclerosisACTRN12623000458639South Australian Health and Medical Research Institute300
进行中（未招募）
1 期
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI)Open randomized 12 month studyEUCTR2013-001178-20-SEppsala University Hospital, MHT, Department of Nephrology105
进行中（未招募）
1 期
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI)Open randomized 12 month studyProphylaxis of graft rejection in adults who have received a renal transplantMedDRA version: 20.0Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000022818EUCTR2013-001178-20-DKppsala University Hospital, MHT, Department of Nephrology110
进行中（未招募）
1 期
Does conversion to Nulojix reduce the risk of cardiovascular disease in kidney transplant recipients?Prophylaxis of graft rejection in adults who have received a renal transplantMedDRA version: 17.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000004865EUCTR2013-001178-20-NLppsale University Hospital, MHT, Department of Nephrology105